Skip to content

Joint care

For over 30 years we have been committed to the treatment of musculoskeletal disease.

+1.7 billion people have musculoskeletal conditions worldwide and up to one third of people of all ages are affected at some point during their lifetime. 

Rheumatic and musculoskeletal diseases comprise more than 200 different painful conditions of the locomotor system, mostly affecting the joints, but also other tissues as well as internal organs. They are usually caused by problems of the immune system and inflammation or gradual deterioration of the locomotor system. Common symptoms are pain, swelling, and stiffness often in conjunction with joint or bone destruction, disability and loss of working capacity. Some of these diseases arise suddenly and are short-lived, but many of them are long term and worsen over time. Rheumatic and musculoskeletal conditions are the leading contributor to disability worldwide. Other patient consequences include impaired quality of life, reduction of physical function and often premature mortality.
Source: WHO, Musculoskeletal health 2022

Prevalent cases of OA increased to 527.81 million in 2019 worldwide.
Osteoarthritis is the single most common cause of disability in older adults. Osteoarthritis (OA) is a long-term chronic disease characterized by the deterioration of cartilage in joints which results in bones rubbing together and creating stiffness, pain and impaired movement. The disease most commonly affects the joints in the knees, hands, feet and spine and is relatively common in shoulder and hip joints. While OA is related to aging, it is also associated with a variety of risk factors, such as obesity, lack of exercise, occupational injury and trauma. Through various strategies spanning from physical therapy to medical devices, from drugs to surgery, the treatment of OA aims to relieve pain and improve function.
Source: Long et al. Arthritis & Rheumatology, Vol. 74, No. 7, July 2022, DOI 10.1002/art.42089

+1.7 billion people have musculoskeletal conditions worldwide
+527 million affected by osteoarthritis worldwide
Our brands